Mdxhealth operates on a calendar basis with its accounting year ending on Dec. 31. The company reports its consolidated financial statements under International Financial Reporting Standards (IFRS) and all amounts are in US Dollars. Mdxhealth publishes a consolidated and audited Annual Report on an annual basis, a consolidated Interim Report for its June 30 half-year financial figures, and business/financial updates at the end of Q1 and Q3.
Furthermore, for the Annual General Shareholders’ Meeting, the company also publishes the non-consolidated Belgian-GAAP financial statements of the parent company. Prior to October 5, 2010, mdxhealth operated under the name OncoMethylome Sciences.
The financial service for the shares of the company is provided in Belgium by KBC. Shareholders should inform themselves about the costs that other financial intermediaries may charge in connection with paying agency services.
Investor Relations Contact
For all investor related questions please call or email:
LifeSci Advisor (PR & IR)